Article Versions Notes

Jalil JE, Gabrielli L, Ocaranza MP, MacNab P, Fernández R, Grassi B, Jofré P, Verdejo H, Acevedo M, Cordova S, et al. New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review. International Journal of Molecular Sciences. 2024; 25(8):4407. https://doi.org/10.3390/ijms25084407

Jalil, Jorge E., Luigi Gabrielli, María Paz Ocaranza, Paul MacNab, Rodrigo Fernández, Bruno Grassi, Paulina Jofré, Hugo Verdejo, Monica Acevedo, Samuel Cordova, and et al. 2024. "New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review" International Journal of Molecular Sciences 25, no. 8: 4407. https://doi.org/10.3390/ijms25084407

Jalil, J. E., Gabrielli, L., Ocaranza, M. P., MacNab, P., Fernández, R., Grassi, B., Jofré, P., Verdejo, H., Acevedo, M., Cordova, S., Sanhueza, L., & Greig, D. (2024). New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review. International Journal of Molecular Sciences, 25(8), 4407. https://doi.org/10.3390/ijms25084407